AES - DRS - Synexus Polska Sp. z o.o. Oddzial w Katowicach

Katowice, Silesian Voivodeship 40-040

0 studies enrolling now · 3 studies all time

What they study most

Plaque Psoriasis, Respiratory Syncytial Virus

Studies at this site

• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age — Completed